Wealthspire Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Wealthspire Advisors, LLC
- $16.6 Billion
- Q1 2025
A detailed history of Wealthspire Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 15,151 shares of CRDL stock, worth $14,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,151
Previous 15,151
-0.0%
Holding current value
$14,999
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
44Shares Held
6.94MCall Options Held
25.9KPut Options Held
1.7K-
Tejara Capital LTD London, X03.19MShares$3.16 Million1.2% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$848,8140.22% of portfolio
-
Ubs Group Ag498KShares$492,8780.0% of portfolio
-
Pvg Asset Management Corp Golden, CO437KShares$432,9881.99% of portfolio
-
Lion Street Advisors, LLC340KShares$336,6240.15% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $61.3M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...